Liras; Spiros

Patent Applications and Registrations

Patent applications and USPTO patent grants for Liras; Spiros.The latest application filed is for "substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of asgpr".

Company Profile

4.14.29

Liras; Spiros - Brookline MA
Liras; Spiros - Stonington CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Tissue-specific genome engineering using CRISPR-Cas9 Grant 10,851,367 - Liras , et al. December 1, 2	2020-12-01
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR Grant 10,813,942 - Liras , et al. October 27, 2	2020-10-27
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol Compounds As Targeting Agents Of Asgpr App 20190321382 - Liras; Spiros ; et al.	2019-10-24
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR Grant 10,376,531 - Liras , et al. A	2019-08-13
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol Compounds As Targeting Agents Of Asgpr App 20180296585 - Liras; Spiros ; et al.	2018-10-18
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR Grant 10,039,778 - Liras , et al. August 7, 2	2018-08-07
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol Compounds As Targeting Agents Of Asgpr App 20170165284 - Liras; Spiros ; et al.	2017-06-15
Tissue-specific Genome Engineering Using Crispr-cas9 App 20170137801 - Liras; Spiros ; et al.	2017-05-18
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR Grant 9,617,293 - Liras , et al. April 11, 2	2017-04-11
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol Compounds As Targeting Agents Of Asgpr App 20160207953 - Liras; Spiros ; et al.	2016-07-21
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR Grant 9,340,553 - Liras , et al. May 17, 2	2016-05-17
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol Compounds As Targeting Agents Of Asgpr App 20150329555 - Liras; Spiros ; et al.	2015-11-19
Benzimidazole and Pyridylimidazole Derivatives App 20100267698 - Li; Guiying ; et al.	2010-10-21
Benzimidazole and pyridylimidazole derivatives Grant 7,642,267 - Li , et al. January 5, 2	2010-01-05
Pyrazole compounds for treatment of neurodegenerative disorders Grant 7,521,464 - Chen , et al. April 21, 2	2009-04-21
Substituted Quinazolines As Pde10 Inhibitors App 20090023756 - Allen; Martin Patrick ; et al.	2009-01-22
Heteroaryl fused azapolycyclic compounds Grant 7,456,177 - Allen , et al. November 25, 2	2008-11-25
Benzimidazole and Pyridylimidazole Derivatives App 20080227793 - Li; Guiying ; et al.	2008-09-18
Benzimidazole and pyridylimidazole derivatives Grant 7,300,945 - Li , et al. November 27, 2	2007-11-27
Pyrazole Compounds For Treatment Of Neurodegenerative Disorders App 20070270474 - Chen; Yuhpyng L. ; et al.	2007-11-22
Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline Grant 7,268,142 - Allen , et al. September 11, 2	2007-09-11
Pyrazole compounds for treatment of neurodegenerative disorders Grant 7,238,721 - Chen , et al. July 3, 2	2007-07-03
3-Azabicyclo[3.1.0]hexane derivatives App 20070054950 - McHardy; Stanton F. ; et al.	2007-03-08
3-azabicyclo[3.1.0]hexane derivatives Grant 7,049,335 - McHardy , et al. May 23, 2	2006-05-23
Benzimidazole and pyridylimidazole derivatives App 20060025425 - Li; Guiying ; et al.	2006-02-02
Novel piperidyl derivatives of quinazoline and isoquinoline App 20060019975 - Humphrey; John Michael ; et al.	2006-01-26
Ligands of adenine nucleotide translocase (ANT) and compositions and methods related thereto App 20060004093 - Ghosh; Soumitra S. ; et al.	2006-01-05
Combination of atypical antipsychotics and 5HT-1B receptor antagonists App 20050256112 - Brodney, Michael A. ; et al.	2005-11-17
Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline App 20050182079 - Allen, Martin Patrick ; et al.	2005-08-18
3-Azabicyclo[3.1.0]hexane derivatives App 20050171178 - McHardy, Stanton F. ; et al.	2005-08-04
4-Phenyl-piperidine compounds and their use as modulators of opioid receptors App 20050032837 - McHardy, Stanton ; et al.	2005-02-10
Heteroaryl fused azapolycyclic compounds App 20050020830 - Allen, Martin P. ; et al.	2005-01-27
3-Benzhydrylidene-8-aza-bicyclo[3.2.1]octane derivatives with opioid receptor activity App 20040254190 - Liras, Spiros	2004-12-16
4-Phenyl-piperidine compounds and their use as modulators of opioid receptors App 20040204453 - McHardy, Stanton ; et al.	2004-10-14
Ligands of adenine nucleotide translocase (ANT) and compositions and methods related thereto App 20040192740 - Ghosh, Soumitra S. ; et al.	2004-09-30
Pyrazole compounds for treatment of neurodegenerative disorders App 20040142997 - Chen, Yuhpyng L. ; et al.	2004-07-22
4,4-Biarylpiperidine derivatives App 20040138220 - Liras, Spiros	2004-07-15
4,4-biarylpiperidine derivatives Grant 6,720,336 - Liras April 13, 2	2004-04-13
3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives App 20040063940 - Liras, Spiros ; et al.	2004-04-01
3-azabicyclo[3.1.0]hexane derivatives App 20030087898 - McHardy, Stanton F. ; et al.	2003-05-08
Benzimidazole and pyridylimidazole derivatives App 20030069257 - Li, Guiying ; et al.	2003-04-10
Use of delta opioid receptor ligands and serotonin reuptake inhibitors in the treatment of chemical dependencies App 20020077323 - McLean, Stafford ; et al.	2002-06-20
4,4-Biarylpiperidine derivatives App 20020013321 - Liras, Spiros	2002-01-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.